Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype-targeted drugs

Authors :: Meltzer, Herbert Y.
Roth, Bryan L.
Source :: Journal of Clinical Investigation. December 2013, Vol. 123 Issue 12, p4986, 6 p.
Publication Year :: 2013
Abstract: Serotonin (5-hydroxytryptamine, or 5-HT) receptors mediate a plethora of physiological phenomena in the brain and the periphery. Additionally, serotonergic dysfunction has been implicated in nearly every neuropsychiatric disorder. The effects [...]

Subjects :: Obesity -- Drug therapy -- Research
Serotonin -- Receptors
Serotonin agonists -- Properties -- Dosage and administration -- Research
Parkinson's disease -- Drug therapy -- Research
Lorcaserin -- Properties -- Dosage and administration -- Research
Cellular signal transduction -- Research
Health care industry
Drug therapy
Research
Properties
Dosage and administration

Tools